Skip to main content
. 2023 Dec 27;47(3):393–400. doi: 10.2337/dc23-1681

Figure 1.

Figure 1

A: PVI at study entry is smaller in individuals who ultimately experienced progression to stage 3 T1D than in individuals who remained in stage 1 or 2. B and C: At study entry, Index60 (B) and DPTRS (C) were higher in individuals who ultimately experienced progression to stage 3 T1D than in individuals who remained in stage 1 or 2. T1D stage at study entry is indicated by shape. *P < 0.05, **P < 0.01. NS, not significant.